Segments - South Korea Patient Monitoring Market by Types of Device, Applications (Cardiology, Neurology, Respiratory, Fetal and Neonatal, Weight Management & Fitness Monitoring, and Others) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The South Korea Patient Monitoring Market size was valued at USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031 expanding at a CAGR of 4.3% during 2023 – 2031. The growth of the market is attributed to increasing burden of chronic diseases in the country.
The patient monitoring system is a set of system or process that enables healthcare provider to monitor a patient’s health. The example of patients monitoring system is an electrocardiography that monitor the electrical activity of the heart.
The monitoring devices are collecting data of vital parameters such as blood pressure and heart rates. The various types of patient monitoring systems are available such as portable, real-time, and wireless. They have main two types bedside patient monitoring system and remote patient monitoring system.
The COVID-19 pandemic affected the demand and supply of South Korea patient monitoring market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. The demand for patient monitoring system and launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.
The report on the South Korea patient monitoring market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Patient Monitoring Market - South Korea Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Applications (Cardiology, Neurology, Respiratory, Fetal and Neonatal, Weight Management & Fitness Monitoring, and Others) |
|
Regional Scope |
South Korea |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Nihon Kohden Corporation; Abbott Laboratories; General Electric Company (GE Healthcare); Dragerwerk AG & Co. KGaA; Koninklijke Philips N.V. |
Based on applications, the South Korea patient monitoring market is divided into cardiology, neurology, respiratory, fetal & neonatal, weight management & fitness monitoring, and other applications. The weight management & fitness monitoring segment is expected to grow at a rapid pace during the forecast period due to adoption of sedentary lifestyle such as poor diet, high consumption of sugar, physical inactivity has led to many chronic diseases such as obesity, diabetes, cardiovascular diseases, and others.
As in the South Korea geriatric population is expected to increase in the coming years who are more prone to chronic diseases such as diabetes and other diseases is expected to drive the market during forecast period. However, the respiratory segment is anticipated to hold a key market share during the forecast period owing to increasing respiratory related diseases such as pneumococcal pneumonia (PP), invasive pneumococcal diseases (IPD) in the aged people required patient monitoring system is expected to fuel the South Korea patient market during the forecast period.
According to the research article by Jung Yeon Heo et al., published in PLOS ONE Journal 2018, incidences of community-acquired pneumonia (CAP) was 307.7 cases per 10000 persons per year.
The South Korea patient monitoring market has been segmented on the basis of
Key players competing in the South Korea patient monitoring market include Nihon Kohden Corporation; Abbott Laboratories; General Electric Company (GE Healthcare); Dragerwerk AG & Co. KGaA; Koninklijke Philips N.V.
These key players are constantly implementing several marketing strategies such as merger & acquisitions, capital investments, partnerships, and new product development to sustain industry position in the market.
The market is segmented by applications, including cardiology, neurology, respiratory, fetal & neonatal, weight management & fitness monitoring, and others.
The report covers historic data from 2016–2021 and provides forecasts for the period 2023–2031.
Major companies covered in the report include Nihon Kohden Corporation, Abbott Laboratories, General Electric Company (GE Healthcare), Dragerwerk AG & Co. KGaA, and Koninklijke Philips N.V.
High costs of patient monitoring systems and the risk of faulty or inaccurate devices leading to incorrect treatments are major restraints for the market.
The weight management and fitness monitoring segment is expected to grow rapidly due to lifestyle changes and rising chronic diseases. The respiratory segment is also anticipated to hold a significant market share due to increasing respiratory illnesses among the elderly.
The main types include bedside patient monitoring systems and remote patient monitoring systems, with various options such as portable, real-time, and wireless devices.
The COVID-19 pandemic disrupted the demand and supply chain, causing temporary declines in market growth. However, the demand for patient monitoring systems increased due to the pandemic, and the launch of vaccines is expected to contribute to future market growth.
Key drivers include the increasing prevalence of chronic and respiratory diseases, advancements in medical research and development, growing health awareness, and the rising geriatric population in South Korea.
Patient monitoring systems are devices or processes that enable healthcare providers to monitor a patient’s health by collecting data on vital parameters such as blood pressure and heart rate. Examples include electrocardiography, bedside monitors, and remote patient monitoring systems.
The South Korea patient monitoring market was valued at USD XX Billion in 2022 and is projected to reach USD XX Billion by 2031, expanding at a CAGR of 4.3% during 2023–2031.